'It's just the beginning' for pancreatic cancer’s long-awaited breakthrough

SAN DIEGO — Since Herceptin's approval in 1998, breast cancer has been reshaped from a near-term death sentence into — in many cases — a chronic disease. Now, researchers hope daraxonrasib from Revolution Medicines will launch the same ...